🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy to present at #AACR25 our work on the interception of FAP-associated colorectal cancer through WNT/β-catenin pathway modulation. Proud to share our research from MD Anderson Cancer Center!

Excited to present our poster on the results of one of Dr. Yap’s Investigator-Initiated Trials at AACR , with additional insights from single-cell analysis performed by Dr. Haymaker’s team. MD Anderson Cancer Center congress.sanofimedical.com/aacr-2025/onco…

🖥️🎯 Happy to present at #AACR2025 the benchmark testing of our academical, independent and budget-friendly trial matcher OncoSolver (OS), that may improve the workflow of patient referrals to trials. Time to start its clinical validation at IEO G Curigliano MD PhD

All 3 will soon be MDACC faculty! Congrats!!!

Our newest publication in ESMO Open! 𝗟𝗶𝗻𝗸 𝘁𝗼 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲: esmoopen.com/article/S2059-…

What an amazing night at the MD Anderson Cancer Center 2025 Faculty honors convocation! Our own Tim Yap aka Taylor Swift took home the DF living legend Faculty achievement in Translational Research! And the most famous TikTok, Twitter/X MD Dr. Glaucomflecken gave the keynote!

Aung Naing and Naveen Pemmaraju, MD More to come at #ASCO2025 #ASCO25 #ASCO #JIPO Yostena Mekhail, MD, PhD @mderbalamd Maria Hafez Carlos Torrado

Presented by Dr. Tim Yap at #ASCO25: BNT142, a bispecific antibody therapy, shows manageable safety and early anti-tumor activity in CLDN6-positive cancers, including ovarian and testicular tumors. First-in-human results are encouraging. #EndCancer

HMPL-306, a novel small-molecular dual inhibitor of IDH1 and IDH2 mutations is safe and well tolerated and showed durable responses in patients with lower-grade gliomas, says our Dr. Jordi Rodon Ahnert in an oral presentation at #ASCO25. ASCO #EndCancer

Amazing #ASCO25 with the (former & current) ICT team!! MD Anderson Cancer Center Harold Nathan Tan Carlos Torrado Mohamed A Gouda David S. Hong MD

“The heterogeneity of sarcomas coupled with their rarity makes them hard to study, and conflicting results from studies add further complexity,” says our Dr. @VinodRavi in an education session on neo/adjuvant therapy for soft tissue sarcoma at #ASCO25. ASCO #EndCancer

ICT fellow’s farewell dinner (but all 3 leaving will be joining as faculty MD Anderson Cancer Center )! 👏👍🥳 Camila Braganca Xavier Carlos Torrado Mohamed A Gouda

Our lovely pic w/ the amazing MD Anderson Cancer Center ICT APPs ⭐️ Thank you for your friendship & support during our Fellowship. I will miss you all incredibly — luckily we will be only 2 floors away! Mohamed A Gouda Carlos Torrado

Huge congratulations! So well deserved!

Today is my first clinic as attending physician at MD Anderson Cancer Center #endcancer #sarcoma

Such an incredible week in San Diego learning clinical trial design! Grateful to connect with these innovators as we wrote our protocols and caught La Jolla sunsets and sea lions.

Had an awesome week in La Jolla at the ASCO/AACR workshop — such a valuable learning experience and a great chance to connect with amazing fellows and mentors!

Back in Houston after an incredible week at ASCO/AACR #MCCR25! Truly honored to be part of the 2025 class of the #VailWorkshop. Grateful for the insights, connections, and inspiration throughout the week! #PDG4